Adaptive Biotechnologies to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Adaptive Biotechnologies (Nasdaq: ADPT) will participate in two investor conferences in late 2025: a presentation at the Jefferies Global Healthcare Conference in London on November 19, 2025 at 8:00 a.m. GMT, and a fireside chat at the Piper Sandler 37th Annual Healthcare Conference in New York on December 3, 2025 at 8:30 a.m. ET.

Interested parties may access live and archived webcasts on the company’s Investors section at www.adaptivebiotech.com.

SEATTLE, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will be participating in the following investor conferences.

• Jefferies Global Healthcare Conference in London, UK
  Presentation on Wednesday, November 19, 2025, at 8:00 a.m. Greenwich Mean Time

• Piper Sandler 37^th Annual Healthcare Conference in New York, NY
  Fireside chat on Wednesday, December 3, 2025, at 8:30 a.m. Eastern Time

Interested parties may access live and archived webcasts of the session on the “Investors” section of the company website at: www.adaptivebiotech.com.

About Adaptive Biotechnologies

Adaptive Biotechnologies (“we” or “our”) is a commercial-stage biotechnology company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. We believe the adaptive immune system is nature’s most finely tuned diagnostic and therapeutic for most diseases, but the inability to decode it has prevented the medical community from fully leveraging its capabilities. Our proprietary immune medicine platform reveals and translates the massive genetics of the adaptive immune system with scale, precision and speed. We apply our platform to partner with biopharmaceutical companies, inform drug development, and develop clinical diagnostics across our two business segments: Minimal Residual Disease (MRD) and Immune Medicine. Our commercial products and clinical pipeline enable the diagnosis, monitoring, and treatment of diseases such as cancer and autoimmune disorders. Our goal is to develop and commercialize immune-driven clinical products tailored to each individual patient.

ADAPTIVE INVESTORS
Karina Calzadilla, Vice President, Investor Relations and FP&A
201-396-1687
investors@adaptivebiotech.com

ADAPTIVE MEDIA
Erica Jones, Associate Corporate Communications Director
206-279-2423
media@adaptivebiotech.com

FAQ

When will Adaptive Biotechnologies (ADPT) present at the Jefferies Global Healthcare Conference?

Adaptive will present on November 19, 2025 at 8:00 a.m. GMT.

What time is the Adaptive Biotechnologies (ADPT) fireside chat at Piper Sandler?

The fireside chat is scheduled for December 3, 2025 at 8:30 a.m. ET.

How can investors watch Adaptive Biotechnologies (ADPT) conference webcasts?

Live and archived webcasts are available on the company Investors page at www.adaptivebiotech.com.

Will the Adaptive Biotechnologies (ADPT) presentations be archived after the conferences?

Yes. The announcement states both live and archived webcasts will be accessible on the Investors site.

Which conferences will Adaptive Biotechnologies (ADPT) attend in November–December 2025?

Jefferies Global Healthcare Conference in London on Nov 19, 2025 and Piper Sandler 37th Annual Healthcare Conference in New York on Dec 3, 2025.

Where can I find the schedule and webcast links for Adaptive Biotechnologies (ADPT) investor events?

Visit the company’s Investors section at www.adaptivebiotech.com for schedules and webcast links.